Validation of the Prognostic Ability of Eight Risk Scores for Cardiovascular Events in NSTEMI Patients with

Chen Wang1, Jiachun Lang1, He Jiao2

  • 1Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.

Angiology
|April 25, 2025
PubMed

Insights

This study evaluated eight risk scores for predicting outcomes in non-ST-elevation myocardial infarction patients with multi-vessel disease after PCI. Clinical variable scores showed better prediction of adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Clinical Risk Stratification
  • Interventional Cardiology

Background:

  • Non-ST-elevation myocardial infarction (NSTEMI) patients with multi-vessel disease (MVD) undergoing percutaneous coronary intervention (PCI) face significant risks.
  • Accurate risk stratification is crucial for optimizing management and improving outcomes in this population.

Purpose of the Study:

  • To compare the predictive accuracy of eight established risk scores in NSTEMI patients with MVD post-PCI.
  • To identify the most effective risk score for predicting cardiac death, major adverse cardiovascular events (MACE), all-cause death, and myocardial infarction (MI).

Main Methods:

  • A cohort of 862 NSTEMI patients with MVD post-PCI was analyzed.
  • Eight different risk scores were evaluated for their predictive performance.
  • Outcomes assessed included cardiac death, MACE, all-cause death, and MI over a median follow-up of 4.8 years.

Main Results:

  • The Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score II demonstrated the highest accuracy for predicting cardiac death (AUC: 0.814).
  • The logistic SYNTAX score extended model (LSSextended) was most powerful for predicting MACE (AUC: 0.624) and MI (AUC: 0.657).
  • The modified Age, Creatinine, and Ejection Fraction score (MAS) excelled in predicting all-cause death (AUC: 0.798).

Conclusions:

  • Risk scores incorporating clinical variables demonstrated superior predictive ability for adverse cardiovascular events in NSTEMI patients with MVD after PCI.
  • The choice of risk score should be tailored to the specific outcome being predicted (e.g., cardiac death, MACE, all-cause death).
  • Further research may refine these scores for enhanced clinical utility in this patient group.